CEO Andreas Bhagwani presents Nanologica’s Interim Report Q3 2022
11 November, 2022
No Comments
Presentations
CEO Comment Q3 2023
11 November, 2022
No Comments
WELL-POSITIONED FOR THE NEXT PHASE Our focus during the third quarter has mainly been on production and financing. We are
Nanologica’s Interim Report Jan-Sep 2022
11 November, 2022
No Comments
Nanologica AB’s Interim Report Jan-Sep 2022 The auditor’s report Q3 2022 (Swedish) Report presentation Q3 2022 FINANCIAL SUMMARY Net
Nanologicas delårsrapport jan – sep 2022
11 November, 2022
No Comments
Nanologicas delårsrapport jan – sep 2022 Revisorns granskningsrapport Q3 2022 Rapportpresentation Q3 2022 FINANSIELL SAMMANFATTNING Nettoomsättningen för tredje kvartalet
Nanologica’s Rights Issue Registered – Conversion of BTA to Shares
8 November, 2022
No Comments
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG, NEW ZEALAND,
Nanologicas företrädesemission registrerad – omvandling av BTA till aktier
8 November, 2022
No Comments
EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARE SIG DIREKT ELLER INDIREKT, I USA, AUSTRALIEN, JAPAN, KANADA, HONG KONG, NYA ZEELAND,